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Population-based GWAS samples and phenotype measurements 
The EArly Genetics and Lifecourse Epidemiology (EAGLE) Consortium is an international 
consortium of pregnancy and birth cohorts that aims to collaborate to investigate the genetic 
basis of phenotypes in antenatal and early life and childhood. EAGLE covers a broad range of 
pathways and phenotypes, integrating closely with the DOHaD (developmental origins of health 
and disease) community. Further details can be found here: http://research.lunenfeld.ca/eagle/. 
Descriptions for each cohort that participated in this study are detailed below. All participants 
provided written informed consent and studies were approved by local Research Ethics 
Committees and/or Institutional Review boards. 
 
Individual Study Cohort Descriptions 
Amsterdam Born Children and their Development (ABCD) 
Study design 
The Amsterdam Born Children and their Development (ABCD) cohort study is a large, 
community-based birth cohort, which started in 2003 with the inclusion of 8,000 pregnant 
women living in Amsterdam and its main aim is to study factors in early life (during pregnancy 
and infancy) that explain health later in life. Detailed information on life style habits, 
psychosocial determinants, obstetric complications, blood pressure course during pregnancy, as 
well as childhood growth patterns has been gathered.1 Data for this study comes from ABCD-
Genetic Enrichment (ABCD-GE) study, a sub-study of 1192 ethnic Dutch children. The blood 
was collected from a simple finger prick during the 5-year health check-up of the children (2008-
2010). DNA was extracted from the dried blood spots.2 Approval of the study was obtained from 
the Central Committee on Research Involving Human Subjects in The Netherlands, the medical 
ethics review committees of the participating hospitals and the Registration Committee of the 
Municipality of Amsterdam and written consent was obtained from participating parents. 
Sleep duration assessment 
At age 7-8, child sleep and sleep problems were assessed using the  Dutch Child Sleep Habit 
Questionnaire3. To assess sleep duration, mothers were asked on “Child’s usual amount of sleep 
each day, combining night time sleep and naps (in hours)”. 
 
Avon Longitudinal Study of Parents and Children (ALSPAC) 
Study design 
The Avon Longitudinal Study of Parents and Children (ALSPAC) is a prospective study, which 
recruited pregnant women with expected delivery dates between April 1991 and December 1992 
from Bristol UK. The study methods are described elsewhere and on the study website 
(www.alspac.bris.ac.uk).4 Ethical approval for the study was obtained from the ALSPAC Ethics 
and Law Committee and the Local Research Ethics Committees. 
Sleep duration assessment 
Sleep duration in children was assessed by parental questionnaire according to the following 
open-ended question: “Normally during term-time what time in the evening does your child go to 
sleep? During term-time what time does she normally wake-up in the morning?” These questions 
were to be answered for school days and weekends separately. Sleep duration in school days was 
used in this study. 
 
  
Brain development and Air pollution ultrafine particles in school children (BREATHE) 
Study design 
The BRain dEvelopment and Air polluTion ultrafine particles in scHool children (BREATHE) is 
a prospective cohort study that aims to analyze the association between air pollution and 
cognitive development of scholars.5 DNA samples from 2,492 children were obtained from 
saliva and a final subset of 1,778 children was selected for genome-wide genotyping after 
applying a filtering criteria (low quality DNA, no neuropsychological data, non-Caucasian 
descent origin and not born in Spain, parents born in Europe, and adopted children). Genome-
wide genotyping was performed at the Spanish National Genotyping Centre (CEGEN) 
coordinated by the Spanish National Cancer Research Centre (CNIO). All parents and legal 
guardians signed the informed consent approved by the Ethical Committee of the IMIM-
ParcSalut Mar. 
Sleep duration assessment 
Child sleep duration was assessed by parental questionnaire according to the following open-
ended question: “How long does your child sleep during weekdays?” 
 
Generation R Study (GEN-R) 
Study design 
The Generation R Study is a population-based prospective cohort study. All children were born 
between April 2002 and January 2006. This study is designed to identify early environmental 
and genetic determinants predictors of growth, development, and health from foetal life until 
young adulthood and has been described previously in detail.6 DNA was extracted from cord 
blood taken at birth. Children of Northern European descent, as determined by principal 
component analyses of genome wide association (GWA) data, were selected. The details of 
DNA extraction, genotyping, imputation, and quality control have been previously described.7 
Of 5,908 children with DNA available, 1,979 children of Northern European descent (52% boys) 
had SNP data and available data on sleep duration. The Medical Ethical Committee of the 
Erasmus Medical Centre, Rotterdam has approved the study protocol, and participants have 
given informed consent in writing. 
Sleep duration assessment 
Sleep duration in children was assessed by parental questionnaire at 24 months. Average sleep 
duration of children per 24 hours was estimated by the number of sleeping hours during both day 
and night. Detailed information on phenotype are published elsewhere.8  
 
Glycyrrhizin in Licorice (GLAKU) 
Study design 
Glaku is an urban community-based cohort comprising 1049 healthy, singleton infants born 
between March and November 1998 in Helsinki, Finland. In 2009–2011, all initial cohort 
members who had given permission to be contacted and whose addresses were traceable (N=920, 
87.7% of the original cohort in 1998) were invited to a follow-up; 692 (75.2%) mothers of the 
adolescent invitees could be contacted by phone. Of them, 451 (65.2% of those who could be 
contacted by phone, 49% of the invited) participated in a follow-up at a mean age of 12.3 years 
(SD=0.5, range 11.0–13.2 years) and 393 gave saliva and 211 blood for genetic analyses. In 277 
participants DNA was extracted from saliva and in 80 participants from leukocytes. After quality 
control procedures 352 samples remained for the analyses. Data on sleep duration at an average 
age of 11.9 (SD=1.3) were available in 321 (n=165, 51.4% girls) of those genotyped 
successfully. Detailed information on the selection of the Glaku participants and on the study 
design can be found elsewhere.9-11 Ethics Committees of the City of Helsinki Health Department 
and Children's Hospital in Helsinki University Central Hospital approved the study protocol. 
Written informed consent was obtained from parent/guardian and child.  
Sleep duration assessment 
Sleep duration was parent-reported and calculated as the arithmetic difference from answers to 
questions “What time does your child go to sleep on schooldays?” (before 19.00/ 19.30/ 20.00/ 
20.30/ 21.00/ 21.30/ 22.00/ 22.30/ 23.00/ 23.30/ 24.00/ 00.30/ 01.00/ 01.30/ 02.00 or later) and  
“What time does your child wake up on  school mornings?” (before 05.00/ 05.30/ 06.00/ 06.30/ 
07.00/ 07.30/ 08.00 or later).  
 
Lifestyle-Immune System- Allergy Study and German Infant Study on the Influence of Nutrition 
Intervention (LISA+GINI) 
Study design 
The “influence of Life-style factors on the development of the Immune System and Allergies in 
East and West Germany PLUS the influence of traffic emissions and genetics” (LISAplus) Study 
is a population based birth cohort study. A total of 3,097 healthy, mature (gestational age over 37 
weeks) neonates with a birth weight over 2500g were recruited between 1997 and 1999 in 
Munich, Leipzig, Wesel and Bad Honnef. A total of 5,991 mothers and their newborns were 
recruited into the German Infant study on the influence of Nutrition Intervention (GINI) between 
September 1995 and June 1998 in Munich and Wesel. Detailed descriptions of the LISA and 
GINI studies have been published elsewhere.12, 13 For both studies, approval by the local Ethics 
Committees and written consent from participant’s families were obtained. 
Sleep duration assessment 
Child sleep duration was assessed by parental questionnaire according to the following open-
ended question: “How many hours does your child sleep on average: In total, number hours per 
day and night.” 
 
Infancia y media ambiente project (INMA) 
Study design 
The INMA—INfancia y Medio Ambiente—(Environment and Childhood) Project is a network 
of birth cohorts in Spain that aim to study the role of environmental pollutants in air, water and 
diet during pregnancy and early childhood in relation to child growth and development.14 Data 
for this study comes from INMA Sabadell, INMA Valencia and INMA Menorca. DNA was 
obtained from cord blood, whole blood or saliva collected at 4years using the Chemagen 
protocol at the Spanish National Genotyping Centre (CEGEN). Children whose parents reported 
to be white and to be born in Spain or in European countries and that were not lost during the 
follow-up were selected for genotyping. The study has been approved by Ethical Committee of 
each participating centre and written consent was obtained from participating parents. 
Sleep duration assessment 
Child sleep and sleep-related habits were assessed by parental questionnaires. To assess sleep 
duration, parents were asked to reply to the following open-ended question: “How long does the 
child sleep per day, including naps (in hours)?”. 
 
  
Table S1: Information on genotyping methods, quality control, imputation and statistical analysis of studies included in GWAS meta-
analysis of sleep duration in children 
 Genotyping and QC  Imputation and analysis  Meta-level QC 
Cohort Platform Caling algorithm MAF 
(%) 
SNP 
call 
rate 
(%) 
P for 
HWE 
Sample 
call rate 
(%)* 
Final N 
SNPs 
 Imputation Analysis 
software 
 Initial N 
SNPs 
Final N 
SNPs** 
% filtered lambda N 
ABCD Illumina  
HumanCoreBeadChip 
Genome Studio >1 >95 >10e-6 >97 277,644  IMPUTE215 SNPTEST16  - - - - 929 
ALSPAC Illumina 550K GenCall >1 >97 >10e-7 >97 488,325  MACH17 
  
30,061,895 8,320,472 27.68% 1.01 5434 
BREATHE Illumina 
HumanCoreBeadChip 
GeneTrain2.0 >1 >95 >10e-6 >97 240,103  IMPUTE2 SNPTEST 37,721,381 6,885,016 18.25% 1.00 1593 
GEN-R Illumina Human 610K & 
660W 
Genome Studio ≥0.1 >97.5 >10e-7 >97.5 518,245  MACH GRIMP18  30,072,738 6,890,910 22.91% 1.00 1979 
GLAKU Illumina Human Omni  
Express Exome 1.2 bead chip 
- >0 >99 >0.005 -   IMPUTE2 SNPTEST  - - - - 321 
INMA Illumina HumanOmni1-Quad 
Beadchip 
GeneTrain2.0 >1 >95 >10e-6 >98 817,131  IMPUTE SNPTEST  38,040,556 6,275,820 16.50% 1.00 940 
LISA+GINI Affymetrix Genome-Wide 
Human SNO Arrays 5.0 and 
6.0 
BRLMM-P (5.0) 
BIRSEEDv2-(6.0) 
>1 >95 >10e-5 >95 351,488 (5.0) 
718,039 (6.0) 
  IMPUTE SNPTEST  13,486,809 5,306,521 39.35% 1.00 608 
*In addition samples were checked for excess of heterozygosity, sex discordances, relatedness and population stratification 
    **filtered by MAF>1% EMAC (expected allele count)>100, imputation quality R2>0.3 or INFO>0.4 
         
Figure S1.  P-Z plots (x-axis: reported p values on –log10 scale, y-axis: p-values calculated from 
the Z-statistics on –log10 scale, using the reported beta estimates and standard errors)for each 
study participating in the GWAS meta-analysis of sleep duration in children (N=10,554). No 
major analytical issues with beta’s, standard errors and p-values were identified (concordance 
with the identity line) 
 
Figure S2.  Effect allele frequency  (EAF) plot reporting study specific allele frequencies against 
allele frequencies expected from 1000 Genome (EUR), for studies participating in the GWAS 
meta-analysis of sleep duration in children (N=10,554). SNPs with deviating allele frequencies 
(red dots) were excluded from further analyses. They are mainly variants named MERGED in 
the 1000G as well as array specific variants. 
Table S2. Results of all suggestive hits (p< 1.00e-05) from GWAS meta-analysis on sleep duration in the discovery phase, BMI 
adjusted model (N =10,502) 
SNP Chr Position Allele 1/2 Frequency 1 Effect (SE) Directiona # hits meta p heterogeneity p b Nearest gene 
rs7121351 11 72698114 A/G 0.89 -0.08 (0.01) ----- 9 2.29e-08 .24 ARAP1 
rs35630915 1 23180489 A/G 0.19 0.07 (0.01) ----- 74 3.08e-07 .50 LUZP1 
rs157274 3 137813539 T/C 0.49 -0.04 (0.01) ----- 1 1.16e-06 .20 SOX14 
rs9819008 3 39581 T/C 0.86 -0.09 (0.02) ----? 2 1.18e-06 .21 LOC642891 
chr12:73456456:I 12 73456456 D/I 0.72 -0.10 (0.02) ?-?-- 1 1.54e-06 .46 NA 
chr6:23513559:D 6 23513559 D/I 0.21 -0.11 (0.02) ?-?-- 3 1.62e-06 .58 NA 
rs1230545 7 52725576 A/C 0.20 0.05 (0.01) +++?+ 2 1.81e-06 .86 LOC100131871 
rs77543094 19 17644050 A/T 0.91 0.09 (0.02) +++-? 3 1.86e-06 .13 FAM129C 
rs60198202 9 28374228 A/G 0.51 -0.04 (0.01) ---+- 19 1.98e-06 .15 LINGO2 
chr2:226028285:D 2 226028285 D/I 0.56 0.09 (0.02) ?+?++ 3 3.52e-06 .42 NYAP2 
rs143415644 12 104391449 T/C 0.05 0.09 (0.02) +++?? 2 3.60e-06 .53 GLT8D2 
rs12539717 7 47322289 T/C 0.70 -0.05 (0.01) ----- 12 3.77e-06 .78 TNS3 
rs190524676 15 75716731 T/G 0.90 0.10 (0.02) ++++? 1 4.25e-06 .67 SIN3A 
rs272021 2 115886612 A/G 0.27 0.06 (0.01) +++?+ 1 4.73e-06 .18 DPP10 
rs4509077 5 133888303 A/C 0.34 -0.04 (0.01) ----- 1 5.68e-06 .92 FSTL4 
rs4791184 17 67741686 T/C 0.22 -0.07 (0.02) ----- 2 7.47e-06 .17 NOL11 
rs7824578 8 8879193 A/T 0.10 -0.09 (0.02) ----? 1 7.54e-06 .98 MFHAS1 
rs72788412 16 48650645 C/G 0.13 -0.06 (0.01) ----- 1 9.18e-06 .51 LOC105371240 
Note: Chr= chromosome, NA, ?=not available 
aorder of participating cohorts: ALSPAC, GEN-R, LISA+GINI, INMA, BREATHE 
bp value showing heterogeneity between the cohorts 
 
 
Table S3a. Results of the replication analysis of the top SNP (rs74506765, chromosome 11q13.4) derived from the GWAS meta-
analysis on sleep duration in children (discovery phase) 
Cohort Allele 1/2 Frequency 1 Effect SE p-value N 
ABCD C/G 0.08 0.01 0.08 0.95 929 
GLAKU C/G 0.04 -0.27 0.11 0.015 321 
 
Table S3b. Results of the replication analysis of proxies to the top SNP (rs74506765, chromosome 11q13.4) derived from the GWAS 
meta-analysis on sleep duration in adults (summary statistics available by Gottlieb et al, 201419) 
SNP Chr Position Allele1/2 Frequency 1 RSquared*  Effect SE p-value N 
rs7121351 11 72698114 A/G 0.84 0.93 0.02 0.01 0.07 38,398 
rs10898869 11 72720908 T/C 0.08 0.85 0.07 0.06 0.25 3,574 
rs10751211 11 72694178 T/C 0.23 0.53 -0.02 0.01 0.14 38,394 
rs1157343 11 72718096 A/G 0.35 0.21 -0.01 0.01 0.47 38,417 
*it refers to the LD threshold with the top SNP (rs74506765) 
 
Table S4. Enriched tissues/cell types identified with DEPICT associated with sleep duration in children (only nominally associated 
shown) 
MeSH term Name MeSH first level term MeSH second level term p FDR 
A10.165.450 Granulation Tissue Tissues Connective Tissue 0.05 > 0.20 
A10.165.450.300 Cicatrix Tissues ConnectiveTissue 0.05 > 0.20 
A05.360.319.114.630.535 Ovarian Follicle Urogenital System Genitalia 0.05 > 0.20 
A11.436.329 Granulosa Cells Cells Epithelial Cells 0.05 > 0.20 
A06.407.312.497.535.300.500 Cumulus Cells (ovarian) Endocrine System Endocrine Glands 0.05 > 0.20 
Note: MeSH term= Medical Subject Headings term, FDR= False Discovery Rate 
 
Table S5. Top 10 enriched gene-sets identified with DEPICT  
Original gene set ID Original gene set description p FDR 
MP:0004984 increasedosteoclastcellnumber 6.60E-06 > 0.20 
MP:0008088 abnormal T-helper 1 cell differentiation 7.52E-06 > 0.20 
ENSG00000160007 ARHGAP35 PPI subnetwork 7.44E-05 > 0.20 
ENSG00000162407 PPAP2B PPI subnetwork 7.55E-05 > 0.20 
ENSG00000162909 CAPN2 PPI subnetwork 8.70E-05 > 0.20 
ENSG00000100811 YY1 PPI subnetwork 1.39E-04 > 0.20 
ENSG00000106123 EPHB6 PPI subnetwork 1.50E-04 > 0.20 
GO:0030888 regulation of B cell proliferation 2.49E-04 > 0.20 
ENSG00000115392 FANCL PPI subnetwork 3.25E-04 > 0.20 
REACTOME_SIGNAL_ATTENUATION Attenuation of insulin receptor signalling 3.71E-04 > 0.20 
 
Note: FDR= False Discovery Rate 
 
 
  
Figure S3.  Manhattan plot of the GWAS meta-analysis of sleep duration in children for the 
BMI adjusted model (N=10,502). The x-axis represents the autosomal chromosomes and the y-
axis represents the –log10(p). The red line indicates genome-wide significance (p=5.00e-08) and 
the blue line indicates suggestive genome-wide significance (p=1.00e-05)  
 
  
Figure S4. Quantile-quantile (QQ) plot showing the probability values from GWAS meta-
analysis of sleep duration for the BMI adjusted model (N=10,502). The red line indicates the 
distribution under the null hypothesis and the shaded area indicates the 95% confidence band   
 
 
  
Table S6. Genetic correlations between sleep duration in children (derived from the GWAS 
summary statistics of the current study, under the BMI adjusted model) and common metabolic 
and psychiatric traits, using LD score regression and GWAS summary statistics data available in 
the literature 
  Sleep duration in children 
Traits N rG (se) p 
Sleep duration (adults)19 47,180 .15 (0.17) 0.37 
Metabolic    
Obesity (children)20 13,848 .06 (0.11) 0.60 
Type 2 diabetes (adults)21 69,033 .23 (0.11) 0.04 
2hrs glucose (adults)22 46,186 .38 (0.22) 0.09 
Psychiatric    
bipolar disorder (adults)23 16,731 .05 (0.14) 0.74 
major depression (adults)24 18,759 .05 (0.17) 0.79 
schizophrenia (adults)25 70,100 -.05 (0.11) 0.63 
ADHD (children/family trios)26 3,351 .42 (0.26) 0.12 
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